• Cy5.5 NHS Ester (Non-Sulfonated): Transforming In Vivo Imagi

  2026-07-21

  Cy5.5 NHS ester (non-sulfonated) enables highly sensitive, low-background covalent labeling for next-generation in vivo fluorescence imaging and tumor visualization. This guide details optimized workflows, troubleshooting, and expert insights to maximize performance in demanding molecular and cellular biology applications.

• Transdermal PTEN mRNA Delivery via HA-LNPs Restores Tumor Su

  2026-07-21

  Kim et al. report a hyaluronate-lipid nanoparticle system for non-invasive, transdermal delivery of PTEN mRNA, enabling local restoration of tumor suppressor activity in melanoma. The study demonstrates effective tumor inhibition and immune activation, highlighting a promising advance for localized mRNA-based cancer immunotherapy.

• BRD4 Inhibition Enhances Erastin-Induced Ferroptosis via ROS

  2026-07-20

  This study demonstrates that BRD4 inhibitors such as I-BET-762 significantly enhance erastin-induced ferroptosis across diverse cancer cell lines by promoting ROS accumulation and suppressing FSP1. The findings clarify mechanistic links between BET inhibition and ferroptotic cell death, offering new insights for translational cancer research.

• DAPT (GSI-IX): Bridging Notch Modulation to Disease Innovati

  2026-07-20

  Explore how DAPT (GSI-IX), a potent γ-secretase inhibitor from APExBIO, is redefining the landscape of translational research across neurodegeneration, cancer, and emerging neuronal infection models. This thought-leadership article connects mechanistic insight with strategic guidance, highlighting protocol best practices, cross-domain opportunities, and the unique value of DAPT for advanced cell fate and disease modeling.

• ER Stress and Cytokine Storms Drive Pro-Metastatic Tumor Sta

  2026-07-19

  Conod et al. (2022) reveal that tumor cells escaping near-lethal damage can acquire stable pro-metastatic states (PAMEs). This mechanistic insight clarifies how metastasis may originate following cell-death-inducing therapies, offering targets for intervention and new directions for modeling tumor progression.

• Optimized hGBA1 mRNA Restores Lysosomal GCase in Gaucher Mod

  2026-07-18

  This study demonstrates the rational engineering of human GBA1 mRNA for enhanced lysosomal β-glucocerebrosidase (GCase) expression and function, providing a promising mRNA-LNP therapy for Gaucher disease. The results highlight superior enzyme activity and stability in both cellular and animal models, offering critical advancements beyond current enzyme replacement approaches.

• 2-APB in Advanced Channel Modulation: Insights and Protocols

  2026-07-17

  Explore how 2-APB (2-aminoethoxydiphenyl borate) empowers cutting-edge research into calcium channel modulation, with protocol guidance and critical analysis of recent mechanistic advances. Discover unique insights beyond established calcium signaling roles.

• Ciclesonide and Desisobutyryl-Ciclesonide: Translational Lev

  2026-07-17

  This thought-leadership article explores the mechanistic strengths and translational promise of ciclesonide and its active metabolite desisobutyryl-ciclesonide. By analyzing their pharmacological precision, in vitro and in vivo efficacy, and emerging intersections with ERAD-hijacking protein degradation strategies, the article provides actionable insights for respiratory disease researchers. Readers will discover how APExBIO’s ciclesonide can be optimally integrated into anti-inflammatory workflows and how recent advances in targeted degradation widen the strategic horizon for translational studies in asthma and allergic rhinitis.

• Applied Workflows with α-Linolenic Acid in Lipid Metabolism

  2026-07-16

  Harness the translational potential of α-Linolenic Acid (ALA) in advanced lipid metabolism, cardiovascular, and immunometabolic research. This guide details stepwise experimental workflows, troubleshooting strategies, and cross-domain insights—backed by APExBIO quality and the latest mechanistic findings—for maximizing reproducibility and impact.

• Carbenoxolone disodium: Technical Guide for 11β-HSD Inhibiti

  2026-07-16

  Carbenoxolone disodium is a potent 11β-hydroxysteroid dehydrogenase inhibitor for dissecting glucocorticoid signaling, gap junction communication, and related pathways in tissue and cell-based research. It is not recommended for in vivo efficacy studies or for applications where precise off-target control is critical.

• Otilonium Bromide: Applied Antimuscarinic Agent Workflows

  2026-07-15

  Otilonium Bromide stands out as a high-purity antimuscarinic agent, empowering neuroscience and smooth muscle researchers to dissect cholinergic signaling with exceptional reproducibility. This article delivers actionable protocol guidance, advanced troubleshooting, and an integration of recent reference breakthroughs for maximizing experimental precision.

• Technical Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-07-15

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus enables efficient synthesis of Cy3-labeled RNA probes optimized for research workflows such as in situ hybridization and Northern blotting. It addresses the need for reproducible, high-yield fluorescent RNA probe preparation in standard laboratory settings, but should not be used for diagnostics or clinical applications.

• Acetoacetic Acid Sodium Salt: Deep Dive into Metabolic Pathw

  2026-07-14

  Explore the multifaceted role of acetoacetic acid sodium salt in energy metabolism research, with a focus on its unique biochemical properties and translational use in diabetes metabolic imbalance studies. This article delivers a distinctive perspective—bridging advanced mechanistic insights and practical assay considerations.

• Laminin (925-933): Mechanistic Insights and Next-Gen Assays

  2026-07-14

  Explore the mechanistic roles of Laminin (925-933), a key laminin B1 chain peptide, in cell adhesion and migration. This article delivers a deeper look at receptor interactions, assay optimization, and how emerging neurodegenerative research refines its use in advanced cell-based studies.

• Cardiogreen (Indocyanine Green): Advancing Diagnostics and T

  2026-07-13

  Explore how Cardiogreen (Indocyanine Green) is revolutionizing both vascular diagnostics and innovative cancer immunotherapy. This article provides a deep dive into mechanistic advances, bridging clinical workflows with emerging immuno-oncology applications.

16321 records 1/1089 page Next 12345 下5页 Last page